Ezetimibe stimulates faecal neutral sterol excretion depending on abcg8 function in mice

Lily Jakulj, Maud N. Vissers, Cindy P. van Roomen, Jelske N. van der Veen, Carlos L. J. Vrins, Cindy Kunne, Frans Stellaard, John J. P. Kastelein, Albert K. Groen

Research output: Contribution to journalArticleAcademicpeer-review

36 Citations (Scopus)

Abstract

Ezetimibe stimulates faecal neutral sterol (FNS) excretion in mice, which cannot be explained by cholesterol absorption inhibition alone. We investigated whether these effects are mediated via the sterol exporter ATP binding cassette transporter G8 (abcg8). Ezetimibe increased FNS excretion 2.7-fold in WT mice and 1.5-fold in abcg8(-/-) mice, without affecting biliary cholesterol secretion. Daily FNS excretion exceeded the sum of dietary cholesterol intake and biliary secretion by about 60%. Ezetimibe enhanced this 'extra' FNS excretion by 3.5-fold and 1.5-fold in wildtype (WT) and abcg8(-/-)mice, respectively. Ezetimibe stimulates fecal sterol excretion of non-biliary and non-dietary origin, probably through stimulation of trans-intestinal cholesterol excretion. We show that this effect depends on intact abcg8 function. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved
Original languageEnglish
Pages (from-to)3625-3628
JournalFEBS letters
Volume584
Issue number16
DOIs
Publication statusPublished - 2010

Cite this